구.농수식품
중앙백신연구소, 서울대학교
Abstract
Guehwan Janga,1, Hokeun Wonb,d,1, Dong-Uk Leeb, Yun-Hee Nohb, Seung-Chul Leeb, Hwan-Won Choib, In-Joong Yoonb, Yoo Jin Leec, Han SangYood, Changhee Leea,*
a Animal Virology Laboratory, School of Life Sciences, BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, 41566, Republic of Korea
b ChoongAng Vaccine Laboratories, Daejeon, 34055, Republic of Korea
c Department of Neural Development and Disease, Korea Brain Research Institute, Daegu, 41068, Republic of Korea
d Department of Infectious Diseases, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea
1The first two authors contributed equally to this work and share co-first authorship.
*Corresponding author
Abstract
We have previously reported the generation of the attenuated KNU-141112-S DEL5/ORF3 virus by continuous propagation of highly virulent G2b porcine epidemic diarrhea virus (PEDV) in Vero cells. The present study aimed to assess the safety of S DEL5/ORF3 and to evaluate its effectiveness as a live vaccine for prime-booster vaccinations. Reversion to virulence experiments revealed that the S DEL5/ORF3 strain retains its attenuated phenotype and genetic stability after five successive passages in susceptible piglets. Pregnant sows were primed orally with an S DEL5/ORF3 live vaccine and boosted intramuscularly twice with a commercial killed vaccine at 2-week intervals prior to parturition. This sow vaccination regimen completely protected nursing piglets against virulent G2b challenge, as evidenced by the increase in survival rate from 0% to 100% and the significant reduction in diarrhea intensity, including the amount and duration of PEDV fecal shedding. In addition, despite a 2–3 day period of weight loss in piglets from vaccinated sows after challenge, their daily weight gain was recovered at 7 days post-challenge and became similar to that of unchallenged pigs from unvaccinated sows over the course of the experiment. Furthermore, strong antibody responses to PEDV were verified in the sera and colostrum of immunized sows with the prime-boost treatment and their offspring. Altogether, our data demonstrated that the attenuated S DEL5/ORF3 strain guarantees the safety to host animals with no reversion to virulence and is suitable as an effective primary live vaccine providing durable maternal lactogenic immunity for passive piglet protection.
Keywords : Porcine epidemic diarrhea virus; Live-attenuated vaccine; Reversion to virulence; Safety; Prime-boost
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기